首页 | 本学科首页   官方微博 | 高级检索  
     


Evaluation of deoxycoformycin in patients with advanced renal cell carcinoma
Authors:Robert S. Witte  Christine Walsh  Hugh Fisher  Martin M. Okem  Douglas J. Reding  Donald L. Trump
Affiliation:(1) University of Wisconsin Clinical Cancer Center, CA 21076 Madison, WI, USA;(2) New York University Medical Center, CA 16395 New York, NY, USA;(3) Albany Medical College, CA 06954 Albany, NY, USA;(4) University of Minnesota, CA 20365 Minneapolis, MN;(5) Present address: Abbot-Northwestern Hospital, Virginia Piper Cancer Institute, Minneapolis, MN, USA;(6) Present address: Gundersen Clinic, LTD, La Crosse, WI, USA;(7) Present address: Marshfield Clinic, Marshfield, WI, USA;(8) Present address: Duke University, Durham, NC, USA;(9) 1836 South Avenue, 54601 La Crosse, WI, USA
Abstract:This study was conducted by the Eastern Cooperative Oncology Group (Paul P. Carbone, M.D., Chairman, CA 21115) and supported by Public Health Service Grants from the NCI, National Institutes of Health, and the Department of Health and Human Services.
Keywords:trimetrexate  antifol  renal cell carcinoma
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号